Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells (2011)

  • Authors:
  • USP affiliated authors: CARBOLANTE, ELISA MARIA DE SOUSA RUSSO - FCFRP ; COVAS, DIMAS TADEU - FMRP
  • USP Schools: FCFRP; FMRP
  • DOI: 10.1007/s10529-010-0387-5
  • Subjects: GENÉTICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10529-010-0387-5 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Biotechnology Letters

    ISSN: 0141-5492

    Citescore - 2017: 1.88

    SJR - 2017: 0.621

    SNIP - 2017: 0.695


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2165520pcd 2165520 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RUSSO-CARBOLANTE, Elisa Maria de Sousa; ALVES, Daiani Cristina Cilião; FERNANDES, Andrielle Castilho; et al. Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnology Letters, Dordrecht, v. 33, n. 1, p. 23-31, 2011. DOI: 10.1007/s10529-010-0387-5.
    • APA

      Russo-Carbolante, E. M. de S., Alves, D. C. C., Fernandes, A. C., Almeida-Porada, G., Tonn, T., Covas, D. T., & Picanço-Castro, V. (2011). Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnology Letters, 33( 1), 23-31. doi:10.1007/s10529-010-0387-5
    • NLM

      Russo-Carbolante EM de S, Alves DCC, Fernandes AC, Almeida-Porada G, Tonn T, Covas DT, Picanço-Castro V. Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnology Letters. 2011 ; 33( 1): 23-31.
    • Vancouver

      Russo-Carbolante EM de S, Alves DCC, Fernandes AC, Almeida-Porada G, Tonn T, Covas DT, Picanço-Castro V. Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnology Letters. 2011 ; 33( 1): 23-31.

    Referências citadas na obra
    Antequera F, Bird A (1999) CpG islands as genomic footprints of promoters that are associated with replication origins. Curr Biol 9:R661–R667
    Beard BC, Dickerson D, Beebe K, Gooch C, Fletcher J, Okbinoglu T, Miller DG, Jacobs MA, Kaul R, Kiem HP, Trobridge GD (2007) Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 15:1356–1365
    Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672
    Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003a) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256
    Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N et al (2003b) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419
    Hacker CV, Vink CA, Wardell TW, Lee S, Treasure P, Kingsman SM, Mitrophanous KA, Miskin JE (2006) The integration profile of EIAV-based vectors. Mol Ther 14:536–545
    Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 82:9964–9977
    Kustikova O, Fehse B, Modlich U, Yang M, Dullmann J, Kamino K, von Neuhoff N, Schlegelberger B, Li Z, Baum C (2005) Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308:1171–1174
    Laufs S, Guenechea G, Gonzalez-Murillo A, Zsuzsanna Nagy K, Luz Lozano M, del Val C, Jonnakuty S, Hotz-Wagenblatt A, Jens Zeller W, Bueren JA, Fruehauf S (2006) Lentiviral vector integration sites in human NOD/SCID repopulating cells. J Gene Med 8:1197–1207
    Lavie L, Maldener E, Brouha B, Meese EU, Mayer J (2004) The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res 14:2253–2260
    Lewinski MK, Yamashita M, Emerman M, Ciuffi A, Marshall H, Crawford G, Collins F, Shinn P, Leipzig J, Hannenhalli S, Berry CC, Ecker JR, Bushman FD (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2:e60
    Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kuhlcke K, Eckert HG, Fehse B, Baum C (2002) Murine leukemia induced by retroviral gene marking. Science 296:497
    Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2:E234
    Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, Sergi Sergi L, Benedicenti F, Ambrosi A, Di Serio C, Doglioni C, von Kalle C, Naldini L (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24:687–696
    Picanco V, Heinz S, Bott D, Behrmann M, Covas DT, Seifried E, Tonn T (2007) Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter. Cytotherapy 9:785–794
    Picanço-Castro V, Fontes AM, Russo-Carbolante EMS, Covas DT (2008) Lentiviral-mediated gene transfer—a patent review. Exp Opin Therap Patents 18(5):525–539
    Rohdewohld H, Weiher H, Reik W, Jaenisch R, Breindl M (1987) Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J Virol 61:336–343
    Tonn T, Herder C, Becker S, Seifried E, Grez M (2002) Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res 11:695–704
    Venter JC, Adams MD, Meyers E, Li PW, Mural RJ et al. (2001) The Sequence of the Human Genome. Science 1304–1351
    Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749–1751